Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Viridian Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 229
- +62 vs. Q3 2025
- Shares held
- 107.8M
- +14.6M (+15.7%) vs. Q3 2025
- Total value
- $3.36B
- +$1.34B (+66.9%) vs. Q3 2025
- New holders
- 77
- 85 more added
- Sold out
- 15
- 45 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $2.50B |
| Q1 2026 | 225 | $2.21B |
| Q4 2025 | 229 | $3.36B |
| Q3 2025 | 169 | $2.01B |
| Q2 2025 | 171 | $1.32B |
| Q1 2025 | 177 | $1.23B |
| Q4 2024 | 179 | $1.75B |
| Q3 2024 | 165 | $1.98B |
| Q2 2024 | 138 | $906.2M |
| Q1 2024 | 136 | $1.24B |
| Q4 2023 | 132 | $1.31B |
| Q3 2023 | 124 | $769.9M |
| Q2 2023 | 128 | $1.12B |
| Q1 2023 | 135 | $1.10B |
| Q4 2022 | 122 | $1.21B |
| Q3 2022 | 105 | $778.5M |
| Q2 2022 | 84 | $327.7M |
| Q1 2022 | 72 | $460.9M |
| Q4 2021 | 55 | $459.8M |
| Q3 2021 | 39 | $223.7M |
| Q2 2021 | 26 | $109.8M |
| Q1 2021 | 33 | $84.5M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 1,000,717 | $31.1M | 0.02% | +1,000,717 | New |
| JPMorgan Chase & Co | 1,010,260 | $31.4M | 0.00% | +701,127+226.8% | Added |
| Woodline Partners LP | 1,115,929 | $34.7M | 0.13% | +300,444+36.8% | Added |
| Jennison Associates LLC | 1,154,080 | $35.9M | 0.02% | +1,154,080 | New |
| Goldman Sachs Group Inc | 1,264,047 | $39.3M | 0.01% | +499,485+65.3% | Added |
| Marshall Wace, LLP | 1,375,739 | $42.8M | 0.04% | +506,551+58.3% | Added |
| Alliancebernstein L.P. | 1,414,181 | $44.0M | 0.01% | −445,277−23.9% | Reduced |
| Paradigm Biocapital Advisors LP | 1,443,102 | $44.9M | 1.20% | −1,166,251−44.7% | Reduced |
| Kynam Capital Management, LP | 1,470,541 | $45.8M | 2.98% | −2,957,386−66.8% | Reduced |
| Loomis Sayles & Co L P | 1,481,135 | $46.1M | 0.06% | −69,193−4.5% | Reduced |
| Avoro Capital Advisors LLC | 1,500,000 | $46.7M | 0.46% | +1,500,000 | New |
| Morgan Stanley | 1,738,225 | $54.1M | 0.00% | +1,546,284+805.6% | Added |
| Fisher Asset Management, LLC | 1,780,284 | $55.4M | 0.02% | +579,058+48.2% | Added |
| Eversept Partners, LP | 1,782,235 | $55.5M | 3.11% | −142,071−7.4% | Reduced |
| Tang Capital Management LLC | 1,792,626 | $55.8M | 2.76% | −1,050,299−36.9% | Reduced |
| Wellington Management Group LLP | 1,971,411 | $61.4M | 0.01% | +848,879+75.6% | Added |
| Baker Bros. Advisors LP | 1,971,678 | $61.4M | 0.36% | +227,272+13.0% | Added |
| Geode Capital Management, LLC | 1,992,174 | $62.0M | 0.00% | +225,987+12.8% | Added |
| Novo Holdings A/S | 2,380,000 | $74.1M | 5.75% | 00.0% | Unchanged |
| Deep Track Capital, LP | 2,524,833 | $78.6M | 1.79% | −2,855,616−53.1% | Reduced |
| Perceptive Advisors LLC | 3,042,703 | $94.7M | 1.73% | +1,580,303+108.1% | Added |
| Price T Rowe Associates Inc | 3,439,414 | $107.0M | 0.01% | +1,021,310+42.2% | Added |
| State Street Corp | 3,466,560 | $107.9M | 0.00% | +912,394+35.7% | Added |
| VR Adviser, LLC | 3,882,709 | $120.8M | 5.97% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 3,914,458 | $121.8M | 9.27% | +454,545+13.1% | Added |
| Bellevue Group AG | 4,358,527 | $135.6M | 2.57% | +4,358,527 | New |
| Vanguard Group Inc | 5,612,144 | $174.6M | 0.00% | +1,280,161+29.6% | Added |
| BlackRock, Inc. | 6,431,923 | $200.2M | 0.00% | +1,003,402+18.5% | Added |
| FMR LLC | 14,384,456 | $447.6M | 0.02% | +2,135,101+17.4% | Added |
| Commodore Capital LP | 0 | $0 | 0.00% | −3,200,000−100.0% | Sold out |
| Maverick Capital LtdSuperinvestorMaverick Capital | 0 | $0 | 0.00% | −2,212,701−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −245,518−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −154,739−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −83,594−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −51,236−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −39,961−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −22,011−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −8,956−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −6,005−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,756−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −1,632−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −801−100.0% | Sold out |
| Montag A & Associates Inc | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Glenmede Investment Management, LP | – | – | – | – | Not filed |
| Corton Capital Inc. | – | – | – | – | Not filed |